Safety and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: A report on 15 patients

Leukemia Research

Volumn 24, Issue 6, 2000, Pages 491-495

  Bouabdallah, Réda ^a   Coso, Diane ^a   Gonzague Casabianca, Laurence ^a   Alzieu, Claude ^a   Resbeut, Michel ^a   Gastaut, Jean Albert ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Constitutional symptoms; Idiopathic myelofibrosis; Radiotherapy; Response

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYUREA; RECOMBINANT ALPHA INTERFERON; STEROID;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRRADIATION; MALE; MYELOFIBROSIS; NEUTROPENIA; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION RESPONSE; SPLEEN CELL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; RETROSPECTIVE STUDIES; SPLEEN;

EID: 0033994777     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00018-7     Document Type: Article

References (17)

1. Weinstein I.M. Idiopathic myelofibrosis: historical review, diagnosis and management. Blood Rev. 5:1991;98.
2. Reillr J.T. Idiopathic myelofibrosis: pathogenesis, natural history and management. Blood Rev. 11:1997;233.
3. Guardiola P., Esperou H., Cazals-Hatam D., Ifrah N., Jouet J.P., Buzyn A., Sutton L., Gratecos N., Tilly H., Lioure B., Gluckman E. Allogenic bone marrow transplantation for agnogenic myeloid metaplasia. Br. J. Haematol. 98:1997;1004.
4. Besa E.C., Nowell P.C., Geller N.L., Gardner F.H. Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicting response and survival. Cancer. 49:1982;308.
5. Lofvenberg E., Wahlin A., Roos G., Ost A. Reversal of myelofibrosis by hydroxyurea. Eur. J. Haematol. 44:1990;33.
6. List A.F., Doll D.C. Alpha-interferon in the treatment of idiopathic myelofibrosis. Br. J. Haematol. 80:1992;566.
7. Leinweber C., Order S.E., Calkins A.R. Whole abdominal irradiation for the management of gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia. Cancer. 68:1991;1251.
8. Elliott M.A., Tefferi A. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review. Blood Rev. 13:1999;163.
9. Parmentier C., Charbord P., Tibi M., Tubiana M. Splenic irradiation in myelofibrosis. Clinical findings and ferrokinetics. Int. J. Radiat. Oncol. Biol. Phys. 2:1977;1075.
10. Wagner H., McKeough P.G., Desforges J., Madoc-Jones H. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia: results of daily and intermittent fractionation with and without concomitant hydroxyurea. Cancer. 58:1986;1207.
11. Elliott M.A., Chen M.G., Silverstein M.N., Tefferi A. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br. J. Haematol. 103:1998;505.
12. Socie G., Devergie A., Girinsky T., Reiffers J., Vernant J.P., Le Bourgeois J.P., Hervé P., Guyotat D., Maraninchi D., Rio B., Michallet M., Jouet J.P., Milpied N., Leblond V., Pico J., Attal M., Belanger C., Gluckman E., Cosset J.M. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. Int. J. Radiat. Oncol. Biol. Phys. 3:1991;397.
13. Resbeut M., Cowen D., Blaise D., Gluckman E., Cosset J.M., Rio B., Pene F., Milpied N., Cuillere J.C., Reiffers J., Richaud P. Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: Is there a best choice? Int. J. Radiat. Oncol. Biol. Phys. 3:1995;509.
14. Cosset J.M., Socie G., Girinsky T., Dubray P., Fourquet A., Gluckman E. Radiobiological and clinical bases for total body irradiation in the leukemias and lymphomas. Sem. Rad. Onc. 5:1995;1.
15. Wilson J.F., Johnson R.E. Splenic irradiation following chemotherapy in chronic myelogenous leukemia. Radiology. 101:1971;657.
16. Dupriez B., Morel P., Demory J.L., Lai J.L., Simon M., Plantier I., Bauters F. Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system. Blood. 88:1996;1013.
17. Reilly J.T., Snowden J.A., Spearing R.L., Fitzgerald P.M., Jones N., Watmore A., Potter A. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases. Br. J. Haematol. 98:1997;96.